These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10455285)

  • 1. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
    Park HS; Hourani SM
    Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
    Hall DA; Hourani SM
    Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of the longitudinal muscle and the muscularis mucosae of the rat duodenum to adenine and uracil nucleotides.
    Johnson CR; Charlton SJ; Hourani SM
    Br J Pharmacol; 1996 Mar; 117(5):823-30. PubMed ID: 8851497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of suramin on contractions of the guinea-pig vas deferens induced by analogues of adenosine 5'-triphosphate.
    Bailey SJ; Hourani SM
    Br J Pharmacol; 1995 Mar; 114(6):1125-32. PubMed ID: 7620701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.
    Horner S; Menke K; Hildebrandt C; Kassack MU; Nickel P; Ullmann H; Mahaut-Smith MP; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):1-13. PubMed ID: 16158305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
    Hourani SM; Hall DA; Nieman CJ
    Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
    Jin J; Daniel JL; Kunapuli SP
    J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adenosine 5'-triphosphate, uridine 5'-triphosphate, adenosine 5'-tetraphosphate and diadenosine polyphosphates in guinea-pig taenia caeci and rat colon muscularis mucosae.
    Hourani SM; Bailey SJ; Johnson CR; Tennant JP
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):464-73. PubMed ID: 9826069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenine triphosphate nucleotides are antagonists at the P2Y receptor.
    Kauffenstein G; Hechler B; Cazenave JP; Gachet C
    J Thromb Haemost; 2004 Nov; 2(11):1980-8. PubMed ID: 15550030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
    Pearce PH; Wright JM; Egan CM; Scrutton MC
    Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
    Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
    Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors.
    von Kügelgen I; Späth L; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):187-96. PubMed ID: 1448182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of P2-purinoceptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum.
    Brownhill VR; Hourani SM; Kitchen I
    Br J Pharmacol; 1997 Sep; 122(2):225-32. PubMed ID: 9313929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1981 Jun; 73(2):405-8. PubMed ID: 7236992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contractile effects of uridine 5'-triphosphate in the rat duodenum.
    Johnson CR; Hourani SM
    Br J Pharmacol; 1994 Dec; 113(4):1191-6. PubMed ID: 7889272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
    Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
    Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.